GlassScriptPhysician profile
Charmin M Kuhn
NPI 1356349617
$1,099.97
in general payments reported to CMS, 2019-2025
18 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.43 · 2023: $347 · 2024: $262 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.42 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $180.74 | 2023-2025 | Caplyta |
| Axsome Therapeutics, INC. | $136.20 | 2024-2025 | Auvelity |
| Uswm, LLC | $93.84 | 2023 | Lucemyra, Zimhi |
| Novo Nordisk INC | $83.93 | 2023-2025 | Wegovy |
| Mylan Specialty L.P. | $49.69 | 2024 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $49.36 | 2023-2024 | Abilify Asimtufii, Abilify Mycite |
| Vanda Pharmaceuticals INC. | $36.40 | 2025 | Fanapt |
| Neurocrine Biosciences, INC. | $22.25 | 2024 | Ingrezza |
| Hologic Sales and Service, LLC | $20.58 | 2023 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $20.15 | 2025 | |
| Corium, LLC | $19.99 | 2023 | Azstarys |
| Viatris Specialty LLC | $19.86 | 2025 | Yupelri |
| Sumitomo Pharma America, INC. | $18.13 | 2025 | Gemtesa |
| Lundbeck LLC | $17.30 | 2023 | Rexulti |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.38 | 2023 | Trulicity, Mounjaro |
| Sage Therapeutics, LLC | $16.29 | 2025 | Zurzuvae |
| Amgen INC. | $15.46 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charmin Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.